Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

UCLA scientists have identified the protein GPNMB as a critical regulator in the heart’s healing process after a heart attack ...

The field of cardio-immunology has gained significant attention as heart disease has become the leading cause of death globally over the past two decades. Despite advancements in managing hemodynamic ...

As a promising chimeric antigen receptor (CAR) cell therapy, whether CAR macrophages (CAR-Ms ... No toxicities associated with FAP CAR-Ms were detected in the heart or other organs at 2 weeks after ...

Blood was collected from anesthetized animals via heart puncture and collected into Serum-Gel Polypropylene ... CSS and the CpG-induced CSS confirmed expansion of spleen and liver macrophages in both ...

Using animal models, they demonstrated that bone marrow-derived immune cells called macrophages secrete GPNMB, which binds to the receptor GPR39, promoting heart repair. These findings offer a new ...

Scientists have identified the protein GPNMB as a critical regulator in the heart's healing process after a heart attack. UCLA scientists have identified the protein GPNMB as a critical regulator ...

UCLA researchers have identified a protein that may help the heart recover after a heart attack. By promoting tissue repair, this protein could help prevent heart failure and improve heart health.

If you have these three concerning symptoms, it’s time to get to the heart of the problem. Dr. Jeremy London, a heart surgeon based in Savannah, Georgia, warns that struggling to breathe while ...

In the new work, the scientists discovered that when the heart is in a diseased state, the regulatory gene Brd4 is turned on in macrophages, and it makes the immune cells produce IL-1β ...